APA (7th ed.) Citation

Hiken, J., Earls, J., Flanagan, K. C., Wellinghoff, R. L., Ponder, M., Messina, D. N., . . . Duncavage, E. J. Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma. BMC.

Chicago Style (17th ed.) Citation

Hiken, Jeffrey, Jon Earls, Kevin C. Flanagan, Rachel L. Wellinghoff, Michelle Ponder, David N. Messina, Jarret I. Glasscock, and Eric J. Duncavage. Analytical Performance of OncoPrism-HNSCC, an RNA-based Assay to Inform Immune Checkpoint Inhibitor Treatment Decisions for Recurrent/metastatic Head and Neck Squamous Cell Carcinoma. BMC.

MLA (9th ed.) Citation

Hiken, Jeffrey, et al. Analytical Performance of OncoPrism-HNSCC, an RNA-based Assay to Inform Immune Checkpoint Inhibitor Treatment Decisions for Recurrent/metastatic Head and Neck Squamous Cell Carcinoma. BMC.